[Cell Death & Disease] The authors investigated the role of endothelial IRE1 signaling in traumatic brain injury using endothelial cell-specific IRE1 conditional knockout mice subjected to cortical ablation.
[Communications Biology] Investigators devised a multilayered experimental plan to decipher the biological mechanisms underlying TRIM47’s role in cerebral small vessel disease pathophysiology.
[International Journal of Molecular Medicine] Scientists evaluated the therapeutic potential of ebastine as a repurposing candidate to overcome trastuzumab resistance by targeting HER2 signaling and CSC‑associated phenotypes in HER2‑positive breast cancer cells.
[Stem Cell Research & Therapy] Investigators observed that oxysterol-binding protein-like 2 (OSBPL2) reduced cholesterol content by HPLC-MS. It inhibited the accumulation of lipid droplets in lung cancer.
[Scientific Reports] The authors investigated how SHH pathway inhibition affects both bulk glioblastoma (GBM) cells and CD133+ GBM cells, with particular emphasis on the influence of astrocyte co-culture, which more closely mimics the brain tumor microenvironment.
[Nature] Scientists dissected the mutational processes shaping the genomes of 959 donors from the Pan Prostate Cancer Group, identifying the etiologies and mutational processes that drive the genomic and clinical heterogeneity of prostate cancer.
[Nature Cancer] Researchers found that oral administration of Nakaseomyces glabratus to castrated mice accelerated prostate cancer progression by promoting infiltration and activation of polymorphonuclear myeloid-derived suppressor cells.
[Nature Communications] Investigators showed that genetic loss of NCOA6 accelerates tumor growth in human pancreatic cancer xenografts, induces prostate tumorigenesis in mice, and cooperates with Pten haploinsufficiency to drive aggressive metastatic pancreatic cancer.